Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Allergy and Asthma Research Center
mi
from
San Antonio, TX
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Allergy and Asthma Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Allergy Associates of Utah
mi
from
Murray, UT
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Allergy Associates of Utah
mi
from
Murray, UT
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Commonwealth Clinical Research Specialists, Inc.
mi
from
Richmond, VA
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Commonwealth Clinical Research Specialists, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Washington Univ School of Med
mi
from
Seattle, WA
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Washington Univ School of Med
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Premier Clinical Research
mi
from
Spokane, WA
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Instituto de Investigaciones Clinicas-Mar del Plata
mi
from
Buenos Aires,
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Instituto de Investigaciones Clinicas-Mar del Plata
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
American Health Research Inc.
mi
from
Charlotte, NC
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
American Health Research Inc.
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Gastonia
mi
from
Gastonia, NC
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Gastonia
mi
from
Gastonia, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Bernstein Clinical Research Center
mi
from
Cincinnati, OH
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Bernstein Clinical Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
South Texas Allergy and Asthma Medical Professionals
mi
from
San Antonio, TX
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
South Texas Allergy and Asthma Medical Professionals
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
IMMUNOe Research Centers
mi
from
Centennial, CO
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
IMMUNOe Research Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Hickory Research Center
mi
from
Hickory, NC
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Hickory Research Center
mi
from
Hickory, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Mainland Medical Research Institute
mi
from
Dickinson, TX
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Mainland Medical Research Institute
mi
from
Dickinson, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated:  12/31/1969
Metroplex Pulmonology & Sleep Center
mi
from
McKinney, TX
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Status: Enrolling
Updated: 12/31/1969
Metroplex Pulmonology & Sleep Center
mi
from
McKinney, TX
Click here to add this to my saved trials
The Breathe Well Program for Adults With Asthma
The Breathe Well Program to Improve Asthma Outcomes
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente of Colorado
mi
from
Denver, CO
The Breathe Well Program for Adults With Asthma
The Breathe Well Program to Improve Asthma Outcomes
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient
Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient a Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center
mi
from
Dallas, TX
Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient
Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Birmingham, AL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Montgomery, AL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Phoenix, AZ
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Surprise, AZ
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Surprise, AZ
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Tempe, AZ
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Little Rock, AR
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Anaheim, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Encinitas, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Encinitas, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Escondido, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Escondido, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Fullerton, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Fullerton, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Huntington Beach, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Long Beach, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Los Angeles, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Newport Beach, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
North Hollywood, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
North Hollywood, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Rolling Hills Estates, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Sacramento, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
San Diego, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
San Jose, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
San Jose, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Tustin, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Tustin, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Westminster, CA
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Westminster, CA
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Boulder, CO
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Boulder, CO
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Colorado Springs, CO
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Denver, CO
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Greenwood, CO
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Greenwood, CO
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Wheat Ridge, CO
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Aventura, FL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Clearwater, FL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Daytona Beach, FL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Doral, FL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Doral, FL
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Gainesville, FL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated:  12/31/1969
Chiesi Investigational Site
mi
from
Hialeah, FL
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Chiesi Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials